Zentiva Completes Voluntary Public Purchase Offer for APONTIS PHARMA AG
December 9, 2024
Zentiva has completed its voluntary public purchase offer for the shares of APONTIS PHARMA AG. Following settlement, Zentiva holds approximately 83.57% of the share capital and approximately 85.27% of the voting rights, with management agreeing to terminate the shares’ inclusion in trading on the Freiverkehr immediately after settlement.
- Buyers
- Zentiva AG
- Targets
- APONTIS PHARMA AG
- Platforms
- Zentiva AG
- Industry
- Pharmaceuticals
- Location
- Germany
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.